• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

IFN-conditioned dendritic cells for the therapy of melanoma: what is missing?

作者信息

Alexandrescu Doru T, Ichim Thomas E, Riordan Neil H, Marincola Francesco M, Dasanu Constantin A

机构信息

Division of Dermatology, University of California at San Diego, CA.

出版信息

J Immunother. 2011 Oct;34(8):607-609. doi: 10.1097/CJI.0b013e31822b9ffc.

DOI:10.1097/CJI.0b013e31822b9ffc
PMID:22025902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3184394/
Abstract
摘要

相似文献

1
IFN-conditioned dendritic cells for the therapy of melanoma: what is missing?用于黑色素瘤治疗的干扰素调节树突状细胞：还缺什么？
J Immunother. 2011 Oct;34(8):607-609. doi: 10.1097/CJI.0b013e31822b9ffc.
2
Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival.在患者特异性树突状细胞免疫治疗中使用的黑色素瘤细胞对干扰素-γ促凋亡作用的抵抗与改善的总生存相关。
Cancer Immunol Immunother. 2011 Jan;60(1):123-31. doi: 10.1007/s00262-010-0925-y. Epub 2010 Oct 20.
3
Photodynamic Modulation of Type 1 Interferon Pathway on Melanoma Cells Promotes Dendritic Cell Activation.光动力调节黑素瘤细胞 I 型干扰素通路促进树突状细胞的激活。
Front Immunol. 2019 Nov 8;10:2614. doi: 10.3389/fimmu.2019.02614. eCollection 2019.
4
Immunomodulatory Protective Effects of Rb9 Cyclic-Peptide in a Metastatic Melanoma Setting and the Involvement of Dendritic Cells.Rb9 环状肽在转移性黑色素瘤模型中的免疫调节保护作用及其与树突状细胞的关系。
Front Immunol. 2020 Jan 15;10:3122. doi: 10.3389/fimmu.2019.03122. eCollection 2019.
5
TLR7 agonist 852A inhibition of tumor cell proliferation is dependent on plasmacytoid dendritic cells and type I IFN.Toll样受体7激动剂852A对肿瘤细胞增殖的抑制作用依赖于浆细胞样树突状细胞和I型干扰素。
J Interferon Cytokine Res. 2008 Apr;28(4):253-63. doi: 10.1089/jir.2007.0097.
6
Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.通过CD56(高+)干扰素-α诱导的树突状细胞进行Vγ9γδT细胞扩增，有效诱导黑色素瘤抗原特异性CD8+ T细胞。
Exp Dermatol. 2015 Jan;24(1):35-41. doi: 10.1111/exd.12581. Epub 2014 Dec 8.
7
Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.用黑色素瘤抗原A/MART-1和糖蛋白100肽联合干扰素α对IV期黑色素瘤患者进行免疫治疗，可激活特异性CD8(+) T细胞和单核细胞/树突状细胞前体。
Cancer Res. 2006 May 1;66(9):4943-51. doi: 10.1158/0008-5472.CAN-05-3396.
8
Systemic immune changes associated with adjuvant interferon-α2b-therapy in stage III melanoma patients: failure at the effector phase?III期黑色素瘤患者辅助性α-2b干扰素治疗相关的全身免疫变化：效应阶段的失败？
Melanoma Res. 2015 Aug;25(4):357-61. doi: 10.1097/CMR.0000000000000171.
9
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma.达卡巴嗪治疗后瘤内注射干扰素-α 树突状细胞可激活抗肿瘤免疫：晚期黑色素瘤I期试验结果
J Transl Med. 2015 May 2;13:139. doi: 10.1186/s12967-015-0473-5.
10
Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cells.
Cancer Res. 2002 Jun 15;62(12):3453-8.

本文引用的文献

1
Interferon-conditioned dendritic cells for melanoma immunotherapy.
J Immunother. 2011 Oct;34(8):606-7; author reply 607-9. doi: 10.1097/CJI.0b013e31822b9fc7.
2
IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity.IFN-α 通过调节蛋白酶体活性增强树突状细胞的表位交叉呈递。
Immunobiology. 2011 May;216(5):537-47. doi: 10.1016/j.imbio.2010.10.003. Epub 2010 Oct 21.
3
Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma.多中心 II 期研究：用黑色素瘤细胞裂解物致敏的成熟树突状细胞治疗晚期黑色素瘤患者。
J Transl Med. 2010 Sep 27;8:89. doi: 10.1186/1479-5876-8-89.
4
Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patients.达卡巴嗪治疗在前，肽疫苗接种在后，可增加黑色素瘤患者中黑色素瘤特异性、肿瘤反应性 CTL 的 T 细胞受体库多样性。
Cancer Res. 2010 Sep 15;70(18):7084-92. doi: 10.1158/0008-5472.CAN-10-1326. Epub 2010 Sep 7.
5
Antiproliferative Properties of Type I and Type II Interferon.I型和II型干扰素的抗增殖特性。
Pharmaceuticals (Basel). 2010 Mar 30;3(4):994-1015. doi: 10.3390/ph3040994.
6
Immunotherapy for melanoma: current status and perspectives.黑色素瘤的免疫治疗：现状与展望。
J Immunother. 2010 Jul-Aug;33(6):570-90. doi: 10.1097/CJI.0b013e3181e032e8.
7
Improved survival with ipilimumab in patients with metastatic melanoma.Ipilimumab 改善转移性黑色素瘤患者的生存。
N Engl J Med. 2010 Aug 19;363(8):711-23. doi: 10.1056/NEJMoa1003466. Epub 2010 Jun 5.
8
Exosomes derived from interleukin-10-treated dendritic cells can inhibit trinitrobenzene sulfonic acid-induced rat colitis.白细胞介素-10处理的树突状细胞来源的外泌体可抑制三硝基苯磺酸诱导的大鼠结肠炎。
Scand J Gastroenterol. 2010 Oct;45(10):1168-77. doi: 10.3109/00365521.2010.490596.
9
Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma.转移性黑色素瘤患者中树突状细胞疫苗接种联合CTLA4阻断治疗
Clin Cancer Res. 2009 Oct 1;15(19):6267-76. doi: 10.1158/1078-0432.CCR-09-1254. Epub 2009 Sep 29.
10
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.达卡巴嗪（DTIC）与自体肽脉冲树突状细胞（DC）疫苗用于转移性黑色素瘤患者一线治疗的比较：DeCOG DC研究组的一项随机III期试验
Ann Oncol. 2006 Apr;17(4):563-70. doi: 10.1093/annonc/mdj138. Epub 2006 Jan 17.